Medicare Enrolled
Dr. Steven Forman, M.D.
Interventional Cardiology · Los Alamitos, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Forman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Forman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Forman
Dr. Steven Forman is an interventional cardiology specialist in Los Alamitos, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Forman performed 3,040 Medicare services across 2,217 unique beneficiaries.
Between the years covered by Open Payments, Dr. Forman received a total of $24,446 from 50 pharmaceutical and/or device companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Forman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 40% volume in CA
$24,446 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,040
Medicare services
Top 40% in CA for interventional cardiology
2,217
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~160 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
782 | $7 | $18 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
722 | $100 | $240 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
156 | $171 | $487 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
150 | $101 | $218 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
149 | $170 | $466 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
141 | $11 | $42 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
102 | $74 | $163 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in one arm or leg using compression and other maneuvers to assess blood flow and check for blockages. |
73 | $110 | $286 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
70 | $147 | $426 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
56 | $76 | $444 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
54 | $86 | $242 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
52 | $42 | $115 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
50 | $133 | $365 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
45 | $10 | $121 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
40 | $21 | $63 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
39 | $25 | $70 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $67 | $151 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
33 | $54 | $183 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
31 | $66 | $132 |
| Chemical destruction of first incompetent vein with imaging guidance This procedure uses imaging guidance to chemically destroy the first incompetent vein in the arm or leg. |
28 | $1,585 | $4,000 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
28 | $354 | $1,201 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
28 | $1 | $75 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $140 | $318 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
21 | $19 | $53 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
20 | $10 | $36 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
20 | $175 | $586 |
| Cardiac catheterization | 18 | $213 | $652 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
13 | $60 | $180 |
| New patient office visit, complex (60-74 min) | 13 | $180 | $449 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
12 | $618 | $2,790 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
11 | $16 | $47 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
11 | $11 | $31 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
11 | $21 | $56 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.1% high complexity
15.5% medium
73.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$24,446
Total received (2018-2024)
Avg $3,492/year across 7 years
Top 22% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
417
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,390 (67.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,055 (33.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,961
2023
$1,430
2022
$984
2021
$1,477
2020
$2,167
2019
$5,474
2018
$9,952
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$1,976
Novartis Pharmaceuticals Corporation
$256
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
Boston Scientific Corporation
$102
ATRICURE, INC.
$62
PFIZER INC.
$61
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$60
E.R. Squibb & Sons, L.L.C.
$60
Merck Sharp & Dohme LLC
$54
Kiniksa Pharmaceuticals International, plc
$52
SANOFI-AVENTIS U.S. LLC
$25
CVRx, Inc.
$25
iRhythm Technologies, Inc.
$21
Amgen Inc.
$20
HEARTFLOW, INC.
$18
Top 3 companies account for 81.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic Vascular, Inc.
$14,414
Medtronic, Inc.
$2,501
Novartis Pharmaceuticals Corporation
$971
Boehringer Ingelheim Pharmaceuticals, Inc.
$855
Janssen Pharmaceuticals, Inc
$762
Abbott Laboratories
$576
Amgen Inc.
$505
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$391
PFIZER INC.
$383
SANOFI-AVENTIS U.S. LLC
$361
Boston Scientific Corporation
$298
Edwards Lifesciences Corporation
$217
Merck Sharp & Dohme LLC
$179
Bard Peripheral Vascular, Inc.
$168
CVRx, Inc.
$147
E.R. Squibb & Sons, L.L.C.
$137
Kestra Medical Technology Services, Inc.
$112
Janssen Scientific Affairs, LLC
$111
HeartFlow, Inc.
$100
Regeneron Healthcare Solutions, Inc.
$98
iRhythm Technologies, Inc.
$96
Amarin Pharma Inc.
$91
Merck Sharp & Dohme Corporation
$81
ATRICURE, INC.
$77
Bardy Diagnostics, Inc.
$73
AstraZeneca Pharmaceuticals LP
$61
Impulse Dynamics (USA) Inc.
$59
Tactile Systems Technology Inc
$58
Venclose Inc.
$56
Kiniksa Pharmaceuticals International, plc
$52
AtriCure, Inc.
$47
AngioDynamics, Inc.
$34
Biocompatibles, Inc.
$32
BSN Medical Inc
$31
Resmed Corp
$30
ABIOMED
$25
CSL Behring
$25
PORTOLA PHARMACEUTICALS, INC.
$25
Biosense Webster, Inc.
$23
Chiesi USA, Inc.
$22
BIOTRONIK INC.
$19
Allergan Inc.
$19
HEARTFLOW, INC.
$18
Arrow International, Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
Esperion Therapeutics, Inc.
$15
Noden Pharma USA Inc
$15
Lundbeck LLC
$14
Teleflex LLC
$14
Alnylam Pharmaceuticals Inc.
$14
Top 3 companies account for 73.2% of all-time payments
Associated products mentioned in payments ›
AIR 11 · ATRICLIP LAA EXCLUSION SYSTEM · ATRICURE SYNERGY ABLATION SYSTEM · Arcalyst · Assure WCD · Azure · BEVYXXA · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CHANTIX · COBALT DR MRI SURESCAN · COREVALVE EVOLUT R · CUTIMED SORBACT · Carnation Ambulatory Monitor · Carto 3 · Catheter - Specialty Access · ClosureFast · CoreValve Evolut · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVRSF · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · Epi-Sense Guided Coagulation System with VisiTrax · FFRct · FLEXITOUCH · Flexitouch Plus · GENERAL - THERAPIES · General - Therapies · Guidewires · INVOKANA · Impella · JARDIANCE · KENGREAL · LEQVIO · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MITRACLIP · MULTAQ · MYCARELINK · Micra · Models · NEXLETOL · NORTHERA · ONPATTRO · OPTIMIZER · PORTICO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Pacemakers · REVEAL LINQ · Repatha · Reveal LINQ · Sentinel · TEKTURNA · Tendril Pacing Lead · VARITHENA · VENASEAL · VERQUVO · VYNDAQEL · Varithena Administration Pack · Vascepa · VenaSeal · Venclose Maven Catheter · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch · Zephyr Pacemaker
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (67%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Interventional cardiologists within 10 mi
85
Per 100K population
2.7
County median income
$113,702
Nearest hospital
UCI HEALTH - LOS ALAMITOS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Forman is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Forman experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Forman performed 782 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Forman receive payments from pharmaceutical companies?
Yes. Dr. Forman received a total of $24,446 from 50 companies across 417 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Forman's costs compare to other interventional cardiologists in Los Alamitos?
Dr. Forman's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Forman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Los Alamitos
Browse interventional cardiologists in Los Alamitos ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology